• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关注健康与疾病中的肠-肾轴。

Focus on the Gut-Kidney Axis in Health and Disease.

作者信息

Stavropoulou Elisavet, Kantartzi Konstantia, Tsigalou Christina, Konstantinidis Theoharis, Romanidou Gioulia, Voidarou Chrysa, Bezirtzoglou Eugenia

机构信息

Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.

Department of Infectious Diseases, Central Institute, Valais Hospital, Sion, Switzerland.

出版信息

Front Med (Lausanne). 2021 Jan 21;7:620102. doi: 10.3389/fmed.2020.620102. eCollection 2020.

DOI:10.3389/fmed.2020.620102
PMID:33553216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7859267/
Abstract

The recent new developments in technology with culture-independent techniques including genome sequencing methodologies shed light on the identification of microbiota bacterial species and their role in health and disease. Microbiome is actually reported as an important predictive tool for evaluating characteristic shifts in case of disease. Our present review states the development of different renal diseases and pathologies linked to the intestinal dysbiosis, which impacts on host homeostasis. The gastrointestinal-kidney dialogue provides intriguing features in the pathogenesis of several renal diseases. Without any doubt, investigation of this interconnection consists one of the most cutting-edge areas of research with potential implications on our health.

摘要

包括基因组测序方法在内的非培养技术在技术上的最新进展,为微生物群细菌种类的鉴定及其在健康和疾病中的作用提供了线索。微生物组实际上被报道为评估疾病情况下特征性变化的重要预测工具。我们目前的综述阐述了与肠道生态失调相关的不同肾脏疾病和病理状况的发展,这会影响宿主的内环境稳定。胃肠-肾脏对话在几种肾脏疾病的发病机制中具有有趣的特征。毫无疑问,对这种相互联系的研究是最前沿的研究领域之一,对我们的健康具有潜在影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78be/7859267/20c87eb3f449/fmed-07-620102-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78be/7859267/20c87eb3f449/fmed-07-620102-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78be/7859267/20c87eb3f449/fmed-07-620102-g0001.jpg

相似文献

1
Focus on the Gut-Kidney Axis in Health and Disease.关注健康与疾病中的肠-肾轴。
Front Med (Lausanne). 2021 Jan 21;7:620102. doi: 10.3389/fmed.2020.620102. eCollection 2020.
2
Unraveling the Interconnection Patterns Across Lung Microbiome, Respiratory Diseases, and COVID-19.揭示肺微生物组、呼吸道疾病和 COVID-19 之间的关联模式。
Front Cell Infect Microbiol. 2021 Jan 28;10:619075. doi: 10.3389/fcimb.2020.619075. eCollection 2020.
3
Microbiome, Immunosenescence, and Chronic Kidney Disease.微生物组、免疫衰老与慢性肾脏病
Front Med (Lausanne). 2021 Mar 19;8:661203. doi: 10.3389/fmed.2021.661203. eCollection 2021.
4
Exploring a Complex Interplay: Kidney-Gut Axis in Pediatric Chronic Kidney Disease.探索复杂的相互作用:儿科慢性肾脏病中的肾-肠轴。
Nutrients. 2023 Aug 17;15(16):3609. doi: 10.3390/nu15163609.
5
Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases.肠道微生物组的影响:它如何超越消化系统在心血管和肾脏疾病发展中发挥作用。
Microb Pathog. 2021 Mar;152:104583. doi: 10.1016/j.micpath.2020.104583. Epub 2020 Oct 24.
6
Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease.微生物组-代谢组揭示了肠道-肾脏轴对肾脏疾病的影响。
J Transl Med. 2019 Jan 3;17(1):5. doi: 10.1186/s12967-018-1756-4.
7
POTENTIAL THERAPEUTIC OPTIONS TARGETING THE GUT DYSBIOSIS IN CHRONIC KIDNEY DISEASE.靶向慢性肾脏病肠道菌群失调的潜在治疗选择。
Wiad Lek. 2022;75(7):1757-1764. doi: 10.36740/WLek202207127.
8
Impacts of foodborne inorganic nanoparticles on the gut microbiota-immune axis: potential consequences for host health.食源性无机纳米颗粒对肠道微生物群-免疫轴的影响:对宿主健康的潜在影响。
Part Fibre Toxicol. 2020 Jun 1;17(1):19. doi: 10.1186/s12989-020-00349-z.
9
Role of the Microbiome in Gut-Heart-Kidney Cross Talk.微生物组在肠-心-肾串扰中的作用。
Circ Res. 2023 Apr 14;132(8):1064-1083. doi: 10.1161/CIRCRESAHA.123.321763. Epub 2023 Apr 13.
10
Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.神经性厌食症与肠道微生物群:对体重变化及新疗法的影响
Expert Rev Gastroenterol Hepatol. 2022 Apr;16(4):321-332. doi: 10.1080/17474124.2022.2056017. Epub 2022 Mar 22.

引用本文的文献

1
Microbial Metabolites and Cardiovascular Dysfunction: A New Era of Diagnostics and Therapy.微生物代谢产物与心血管功能障碍:诊断与治疗的新时代。
Cells. 2025 Aug 11;14(16):1237. doi: 10.3390/cells14161237.
2
Small intestinal bacterial overgrowth as one of the diagnostic markers of hypertension.小肠细菌过度生长作为高血压的诊断标志物之一。
Sci Rep. 2025 Aug 14;15(1):29785. doi: 10.1038/s41598-025-15536-1.
3
Lacticaseibacillus rhamnosus attenuates uremic toxins in patients with nondialysis chronic kidney disease through the anti-inflammatory molecules.

本文引用的文献

1
Interplay between gut microbiota and antimicrobial peptides.肠道微生物群与抗菌肽之间的相互作用。
Anim Nutr. 2020 Dec;6(4):389-396. doi: 10.1016/j.aninu.2020.09.002. Epub 2020 Oct 8.
2
The Emerging Role of Renal Tubular Epithelial Cells in the Immunological Pathophysiology of Lupus Nephritis.肾脏管状上皮细胞在狼疮肾炎免疫病理生理学中的新作用。
Front Immunol. 2020 Sep 23;11:578952. doi: 10.3389/fimmu.2020.578952. eCollection 2020.
3
Probiotics in Medicine: A Long Debate.医学中的益生菌:一场旷日持久的争论。
鼠李糖乳杆菌通过抗炎分子减轻非透析慢性肾病患者体内的尿毒症毒素。
Sci Rep. 2025 Jul 31;15(1):27990. doi: 10.1038/s41598-025-12768-z.
4
Intestinal Microbiota in Early Life: Latest Findings Regarding the Role of Probiotics as a Treatment Approach for Dysbiosis.早期生命中的肠道微生物群:关于益生菌作为失调治疗方法作用的最新发现
Nutrients. 2025 Jun 21;17(13):2071. doi: 10.3390/nu17132071.
5
Modulating Gut Microbiota with Dietary Components: A Novel Strategy for Cancer-Depression Comorbidity Management.利用膳食成分调节肠道微生物群:癌症-抑郁症共病管理的新策略。
Nutrients. 2025 Apr 29;17(9):1505. doi: 10.3390/nu17091505.
6
Perturbed gut microbiota and serum metabolites are associated with progressive renal fibrosis.肠道微生物群和血清代谢产物紊乱与进行性肾纤维化有关。
Front Med (Lausanne). 2025 Apr 28;12:1489100. doi: 10.3389/fmed.2025.1489100. eCollection 2025.
7
Preventive treatment of tripdiolide ameliorates kidney injury in diabetic mice by modulating the Nrf2/NF-κB pathway.雷公藤甲素的预防性治疗通过调节Nrf2/NF-κB信号通路改善糖尿病小鼠的肾损伤。
Front Pharmacol. 2025 Mar 19;16:1492834. doi: 10.3389/fphar.2025.1492834. eCollection 2025.
8
Lactobacillus paracasei Activates the KDM3A/VAMP1 Axis to Induce Autophagy in Renal Tubular Epithelial Cells in Chronic Kidney Disease.副干酪乳杆菌激活KDM3A/VAMP1轴以诱导慢性肾脏病肾小管上皮细胞自噬
Probiotics Antimicrob Proteins. 2025 Mar 20. doi: 10.1007/s12602-025-10516-3.
9
Understanding dysbiosis and resilience in the human gut microbiome: biomarkers, interventions, and challenges.了解人类肠道微生物群中的生态失调与恢复力:生物标志物、干预措施及挑战。
Front Microbiol. 2025 Mar 4;16:1559521. doi: 10.3389/fmicb.2025.1559521. eCollection 2025.
10
Effects of Dietary Fiber Supplementation on Modulating Uremic Toxins and Inflammation in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.补充膳食纤维对慢性肾脏病患者尿毒症毒素及炎症的调节作用:一项随机对照试验的系统评价与荟萃分析
Toxins (Basel). 2025 Jan 26;17(2):57. doi: 10.3390/toxins17020057.
Front Immunol. 2020 Sep 25;11:2192. doi: 10.3389/fimmu.2020.02192. eCollection 2020.
4
Placental Microbial Colonization and Its Association With Pre-eclampsia.胎盘微生物定植及其与子痫前期的关系。
Front Cell Infect Microbiol. 2020 Aug 12;10:413. doi: 10.3389/fcimb.2020.00413. eCollection 2020.
5
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma.粪便微生物群移植治疗转移性肾细胞癌患者酪氨酸激酶抑制剂诱导的腹泻。
Nat Commun. 2020 Aug 28;11(1):4333. doi: 10.1038/s41467-020-18127-y.
6
Intestinal Dysbiosis and Tryptophan Metabolism in Autoimmunity.肠道菌群失调与自身免疫中的色氨酸代谢
Front Immunol. 2020 Aug 4;11:1741. doi: 10.3389/fimmu.2020.01741. eCollection 2020.
7
The Role of the Gut Microbiota in the Prevention and Management of Gestational Diabetes Mellitus: Are We There Yet?肠道微生物群在妊娠糖尿病的预防和管理中的作用:我们做到了吗?
J Perinat Neonatal Nurs. 2020 Jul/Sep;34(3):195-198. doi: 10.1097/JPN.0000000000000497.
8
Engineering the gut microbiota to treat chronic diseases.肠道微生物组工程治疗慢性疾病。
Appl Microbiol Biotechnol. 2020 Sep;104(18):7657-7671. doi: 10.1007/s00253-020-10771-0. Epub 2020 Jul 21.
9
Exploring the Molecular Mechanisms Underlying the Protective Effects of Microbial SCFAs on Intestinal Tolerance and Food Allergy.探讨微生物 SCFAs 对肠道耐受和食物过敏的保护作用的分子机制。
Front Immunol. 2020 Jun 16;11:1225. doi: 10.3389/fimmu.2020.01225. eCollection 2020.
10
Microbiota and Lifestyle: A Special Focus on Diet.微生物群与生活方式:特别关注饮食。
Nutrients. 2020 Jun 15;12(6):1776. doi: 10.3390/nu12061776.